Username or email *
Password *
Remember me
Login
Lost your password?
No products in the compare.
No products in the wishlist.
No products in the cart.
Indicated for the treatment of patients with WHO class II or III pulmonary hypertension (WHO group 1) to improve exercise capacity and delay clinical deterioration
Tofacitinib Citrate Sustained-release Tablets. 枸橼酸托法替布缓释片.
Ruxolitinib cream 鲁索替尼乳膏
Molnupiravir 莫诺拉韦
Let us work together to protect precious health